VivekSubbiah Profile Banner
Vivek Subbiah, MD Profile
Vivek Subbiah, MD

@VivekSubbiah

Followers
39K
Following
33K
Media
4K
Statuses
29K

Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.

Nashville, TN, USA
Joined March 2015
Don't wanna be here? Send us removal request.
@VivekSubbiah
Vivek Subbiah, MD
6 hours
Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology | Nature Cancer
Tweet card summary image
nature.com
Nature Cancer - Ferber et al. present an autonomous artificial intelligence agent system for deployment of specialized medical oncology computational tools, validating their system across various...
1
3
10
@VivekSubbiah
Vivek Subbiah, MD
6 hours
Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response | Nature Cancer
Tweet card summary image
nature.com
Nature Cancer - Han et al. report the design and characterization of a pressure-fused biomineral tablet for the long-acting sustained release of IL-2, promoting antitumor immune responses in...
1
0
6
@VivekSubbiah
Vivek Subbiah, MD
6 hours
Colorectal cancer cells hijack a brain–gut polysynaptic circuit from the lateral septum to enteric neurons to sustain tumor growth | Nature Cancer
Tweet card summary image
nature.com
Nature Cancer - Li and colleagues report that a septo-enteric polysynaptic circuit that is activated by chronic stress links the brain to the tumor microenvironment to promote colorectal cancer...
1
0
4
@VivekSubbiah
Vivek Subbiah, MD
2 days
Targeting G1–S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors | Nature
Tweet card summary image
nature.com
Nature - Dual cyclin A/B RxL inhibitors selectively kill small cell lung cancer cells and other cancer cells with high E2F activity.
0
1
5
@VivekSubbiah
Vivek Subbiah, MD
2 days
RT @tmprowell: ‼️ Interested in use of registries for #oncology #DrugDevelopment & #regulatory decision-making? Or in pediatric #braintumor….
0
2
0
@BTCCexchange
BTCC
5 days
Bitcoin’s on fire at $112K! Time to flip the charts on BTCC!.Exploring Cryptocurrency with Jaren Jackson Jr.🏀.
0
0
6
@VivekSubbiah
Vivek Subbiah, MD
5 days
RT @OncoDailyGI: Health-Related Quality of Life in KRASG12C-Mutated Colorectal Cancer - @VivekSubbiah . #Colorecta….
0
2
0
@VivekSubbiah
Vivek Subbiah, MD
6 days
RT @chadinabhan: The "CHALLENGE" trial on adjuvant "structured exercise" in colon cancer explained by the PI himself, Dr. Chris Booth on #H….
0
7
0
@VivekSubbiah
Vivek Subbiah, MD
6 days
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial | Nature Medicine
Tweet card summary image
nature.com
Nature Medicine - In the multicenter phase 2 OptiTROP-Lung01 trial in patients with treatment-naive advanced non-small-cell lung cancers, the antibody–drug conjugate sacituzumab tirumotecan...
1
6
9
@VivekSubbiah
Vivek Subbiah, MD
6 days
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial | Journal of Clinical Oncology
Tweet card summary image
ascopubs.org
PURPOSEThe phase III APOLLO trial prospectively compared the efficacy of arsenic trioxide (ATO) in combination with all-trans retinoic acid (ATRA) regimen (ATRA and ATO [ATRA-ATO]) plus low-dose...
0
3
10
@VivekSubbiah
Vivek Subbiah, MD
6 days
Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial - The Lancet Oncology.
2
3
9
@VivekSubbiah
Vivek Subbiah, MD
8 days
Personalized Primary and Secondary Prevention in Ovarian Cancer
Tweet card summary image
jamanetwork.com
This Viewpoint describes available and emerging approaches for prevention and detection of ovarian cancer.
0
0
1
@VivekSubbiah
Vivek Subbiah, MD
9 days
🧬 End of an era in Houston: Honoring my brilliant friend & colleague Dr. Anirban Maitra @Aiims1742 as he wraps up an extraordinary decade at MD Anderson. A towering figure in pancreatic #CancerResearch. NYC & @nyulangone gain a visionary as Director of GI Cancer Center. Onward,.
@eugenekoay
Eugene J. Koay, MD, PhD
10 days
Bittersweet day: said farewell to @Aiims1742 as he departs @MDAndersonNews for NYU (wonderful speech/symposium), & me announced as Scientific Director of the Ahmed Center for Pancreatic Cancer Research (!!). @Aiims1742–thanks for an amazing 12 yrs and prepping me for this role 🙏
Tweet media one
Tweet media two
3
1
24
@thesopawsome
The So Pawsome 🐾
4 months
Always curious and full of energy, Beagles turn every walk into an adventure 🐾🎉.
Tweet media one
95
368
7K